CADX Recent News Cadence Pharmaceuticals Has Retu
Post# of 4
Posted On: 03/02/2014 2:54:48 AM
CADX Recent News
Cadence Pharmaceuticals Has Returned 70.7% Since SmarTrend Recommendation (CADX) Comtex SmarTrend(R) - Fri Feb 28, 4:43PM CST
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire - Fri Feb 28, 3:00PM CST
Patent Update from Mallinckrodt - Analyst Blog Zacks Investment Research - Thu Feb 27, 4:20PM CST
Cadence Pharmaceuticals Stock Sees Short Interest Decline 25.7% MarketNewsVideo.com - Thu Feb 27, 2:05PM CST
BNY Mellon U.S. Master Trust Universe Up 14.4% in 2013 PR Newswire - Wed Feb 26, 7:15AM CST
Shares of CADX Up 71.0% Since Uptrend Call on Shares Comtex SmarTrend(R) - Fri Feb 21, 11:00AM CST
Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc. PR Newswire - Wed Feb 19, 2:48PM CST
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog Zacks Investment Research - Wed Feb 19, 8:27AM CST
SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc Business Wire - Mon Feb 17, 12:54PM CST
This Week in Biotech: Three Strikes and You're Out! Motley Fool - Sat Feb 15, 1:10PM CST
Cadence Pharmaceuticals Has Returned 70.7% Since SmarTrend Recommendation (CADX) Comtex SmarTrend(R) - Fri Feb 28, 4:43PM CST
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire - Fri Feb 28, 3:00PM CST
Patent Update from Mallinckrodt - Analyst Blog Zacks Investment Research - Thu Feb 27, 4:20PM CST
Cadence Pharmaceuticals Stock Sees Short Interest Decline 25.7% MarketNewsVideo.com - Thu Feb 27, 2:05PM CST
BNY Mellon U.S. Master Trust Universe Up 14.4% in 2013 PR Newswire - Wed Feb 26, 7:15AM CST
Shares of CADX Up 71.0% Since Uptrend Call on Shares Comtex SmarTrend(R) - Fri Feb 21, 11:00AM CST
Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc. PR Newswire - Wed Feb 19, 2:48PM CST
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog Zacks Investment Research - Wed Feb 19, 8:27AM CST
SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc Business Wire - Mon Feb 17, 12:54PM CST
This Week in Biotech: Three Strikes and You're Out! Motley Fool - Sat Feb 15, 1:10PM CST
(0)
(0)